Centennial Wealth Advisory LLC Purchases 82 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Centennial Wealth Advisory LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 11.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 816 shares of the healthcare conglomerate’s stock after purchasing an additional 82 shares during the quarter. Centennial Wealth Advisory LLC’s holdings in UnitedHealth Group were worth $477,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. China Universal Asset Management Co. Ltd. increased its stake in UnitedHealth Group by 20.6% in the 1st quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock valued at $5,376,000 after buying an additional 1,857 shares during the last quarter. Quent Capital LLC grew its position in shares of UnitedHealth Group by 5.5% in the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock valued at $2,076,000 after purchasing an additional 217 shares during the last quarter. Embree Financial Group grew its holdings in UnitedHealth Group by 12.1% in the 1st quarter. Embree Financial Group now owns 613 shares of the healthcare conglomerate’s stock valued at $303,000 after buying an additional 66 shares in the last quarter. Valley Wealth Managers Inc. increased its position in UnitedHealth Group by 8.7% during the first quarter. Valley Wealth Managers Inc. now owns 1,149 shares of the healthcare conglomerate’s stock worth $568,000 after acquiring an additional 92 shares during the period. Finally, SPC Financial Inc. raised its position in shares of UnitedHealth Group by 3.6% in the first quarter. SPC Financial Inc. now owns 5,185 shares of the healthcare conglomerate’s stock valued at $2,565,000 after buying an additional 179 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the stock. Stephens lowered their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. TD Cowen raised their target price on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. UBS Group decreased their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their target price for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Finally, Cantor Fitzgerald upped their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded up $30.84 on Wednesday, hitting $597.87. The company’s stock had a trading volume of 911,396 shares, compared to its average volume of 3,873,597. The company has a market capitalization of $552.09 billion, a price-to-earnings ratio of 36.94, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. The stock has a 50 day moving average of $580.96 and a 200-day moving average of $543.36. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the company posted $6.56 earnings per share. As a group, research analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.40%. UnitedHealth Group’s payout ratio is presently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.